Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
06/2012
06/07/2012WO2012075393A2 Activators of proteasomal degradation and uses thereof
06/07/2012WO2012075381A1 Substituted purine and 7 - deazapurine compounds as modulators of epigenetic enzymes
06/07/2012WO2012075286A2 Intrapulmonary benzodiazepine for the treatment and prevention of seizures
06/07/2012WO2012075242A2 Controlled chemical release of hydrogen sulfide
06/07/2012WO2012074926A1 Novel azetidine derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012WO2012074773A1 Personalized drug treatment methods
06/07/2012WO2012074769A1 3-substituted-6-(pyridinylmethoxy)-pyrrolopyridine compounds
06/07/2012WO2012074137A1 Method for evaluating drug sensitivity by voltage-dependent calcium channel genetic analysis
06/07/2012WO2012074120A1 Lissencephaly therapeutic agent
06/07/2012WO2012074069A1 Novel compound and medical use thereof
06/07/2012WO2012074068A1 Method for producing hematopoietic stem cells using pyrazole compound
06/07/2012WO2012074043A1 Therapeutic agent for traumatic neurological disorders
06/07/2012WO2012074040A1 Buguanide derivative compound
06/07/2012WO2012073146A1 Kat ii inhibitors
06/07/2012WO2012073143A1 Kat ii inhibitors
06/07/2012WO2012072977A2 Compound formulations
06/07/2012WO2012072840A1 Use of rgs-14 protein for the prevention and/or treatment of a cognitive disorder and/or a memory disorder
06/07/2012WO2012072791A2 2-(1-phenyl-4,5,6,7-tetrahydro-1h-indazol-4-yl)ethylamine derivatives useful as sigma receptor inhibitors
06/07/2012WO2012072665A1 Compositions comprising pipamperone and serotonin antagonist reuptake inhibitors
06/07/2012WO2012072620A1 7-nitro-5-phenyl-1-(pyrrolidin-1-ylmethyl)-1h-benzo[e][1,4]diazepin-2(3h)-one and other benzodiazepine derivatives
06/07/2012WO2012072512A1 N-cyclobutyl-imidazopyridine or -pyrazolopyridine carboxamides as trpv1 antagonists
06/07/2012WO2012072256A2 Once daily formulation of lacosamide
06/07/2012WO2012072200A1 3-hetaryl-substituted pyrrolo[2,3-b]pyridine derivatives as pdk1 inhibitors
06/07/2012WO2012072014A1 Transdermal patch preventing volatilization of rasagiline
06/07/2012WO2012044046A3 Novel methylcyclohexane derivatives and uses thereof
06/07/2012WO2012040641A3 Compounds for treating neurodegenerative diseases
06/07/2012WO2012039979A3 Rapid diffusion of large polymeric nanoparticles in the mammalian brain
06/07/2012WO2012019106A3 Compounds for use in modulating the nmda receptor
06/07/2012WO2011156003A3 Peptoid and synthetic oligomers, pharmaceutical compositions and methods of using same
06/07/2012US20120142786 Oregano extract for alertness
06/07/2012US20120142785 Methods for treating alzheimer's disease
06/07/2012US20120142781 Antagonists of the Magnesium Binding Defect as Therapeutic Agents and Methods for Treatment of Abnormal Physiological States
06/07/2012US20120142778 Microbiological method for synthesizing cinnamoyl amide derivatives of amino acids
06/07/2012US20120142777 Pharmaceutical composition comprising gabapentin or an analogue thereof and an alpha-aminoamide and its analgesic use
06/07/2012US20120142775 Treatment of neurodegenerative conditions
06/07/2012US20120142771 Biphenylacetamide derivative
06/07/2012US20120142758 Treatment of down syndrome gene related diseases by inhibition of natural antisense transcript to a down syndrome gene
06/07/2012US20120142751 Methods for the production of biliverdin
06/07/2012US20120142748 Novel cannabinoid receptor ligands, pharmaceutical compositions containing them, and process for their preparation
06/07/2012US20120142744 Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives
06/07/2012US20120142743 Pharmaceutically acceptable salt and polymorphic forms of flupirtine maleate
06/07/2012US20120142740 Novel alkene derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012US20120142739 Novel oxadiazole derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012US20120142736 Novel pyridine derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012US20120142735 Disubstituted [4-(5-aminomethyl-phenyl)-piperidin-1-yl]- 1h-indol-3-yl]-methanones
06/07/2012US20120142733 4-substituted-cyclohexylamino-4-piperidinyl-acetamide antagonists of ccr2
06/07/2012US20120142729 KAT ll INHIBITORS
06/07/2012US20120142728 Chemical compound and its use
06/07/2012US20120142727 Nitrogenous-ring acylguanidine derivative
06/07/2012US20120142726 Pharmaceutical compositions comprising 3,4-dihydroisoquinolin-2(1h)-yl-3-phenylurea derivatives having formyl peptide receptor like-1 (fprl-1) agonist or antagonist activity
06/07/2012US20120142720 Phenylethanoic Acid, Phenylpropanoic Acid and Phenylpropenoic Acid Conjugates and Prodrugs of Hydrocodone, Methods of Making and Use Thereof
06/07/2012US20120142719 Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof
06/07/2012US20120142717 Compounds
06/07/2012US20120142716 4-pyrimidinesulfamide derivative
06/07/2012US20120142699 Trazodone and trazodone hydrochloride in purified form
06/07/2012US20120142695 Compounds as bradykinin b1 antagonists
06/07/2012US20120142692 Antifolate combinations
06/07/2012US20120142691 Picolinamide derivatives as ttx-s blockers
06/07/2012US20120142680 Heteroalkyl linked pyrimidine derivatives
06/07/2012US20120142677 Pyrrolidine Compounds Which Modulate The CB2 Receptor
06/07/2012US20120142674 N-phenyl-(homo)piperazinyl-benzenesulfonyl or benzenesulfonamide compounds suitable for treating disorders that respond to the modulation of the serotonin 5-ht6 receptor
06/07/2012US20120142672 Heterocyclic compound and use thereof
06/07/2012US20120142671 Benzamides and nicotinamides as syk modulators
06/07/2012US20120142666 Azetidine 2-Carboxamide Derivatives Which Modulate The CB2 Receptor
06/07/2012US20120142665 Triazolopyridine compounds
06/07/2012US20120142664 Novel benzyl azetidine derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012US20120142663 Novel azetidine derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012US20120142662 Novel azetidine derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012US20120142661 Novel oxime azetidine derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012US20120142658 Therapeutical use of ternary complexes of valproic acid
06/07/2012US20120142657 Gaba-steroid antagonists and their use for the treatment of cns disorders
06/07/2012US20120142642 Novel oxime derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012US20120142640 Alkyne and alkene derivatives as sphingosine 1-phosphate-1 receptor modulators
06/07/2012US20120142639 Oxadiazole derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012US20120142638 Combination of organic compounds
06/07/2012US20120142636 Novel glucokinase activators and methods of using same
06/07/2012US20120142620 Core 2 glcnac-t inhibitors
06/07/2012US20120142618 Ketogenic saccharides
06/07/2012US20120142615 Methods related to the treatment of neurodegenerative and inflammatory conditions
06/07/2012US20120142610 Treatment of 'iq motif containing gtpase activating protein' (iqgap) related diseases by inhibition of natural antisense transcript to iqgap
06/07/2012US20120142604 Novel applications of hip/pap or derivatives thereof
06/07/2012US20120142602 Composition and Method for Preventing or Treating a Tauopathy
06/07/2012US20120142601 Modified Peptides and Uses Thereof
06/07/2012US20120142596 Agent for stimulating mobilization of endothelial progenitor cells
06/07/2012US20120142595 Tissue protective peptides and uses thereof
06/07/2012US20120142591 Method of treating intraoccular tissue pathologies with nerve growth factor
06/07/2012US20120142589 Tissue-protective cytokines for the protection, restoration and enhancement of responsive cells, tissues and organs
06/07/2012US20120142584 Novel transporter constructs and transporter cargo conjugate molecules
06/07/2012US20120141588 Dentifrice compositions containing calcium silicate and a basic amino acid
06/07/2012US20120141583 Alcohol resistant dosage forms
06/07/2012US20120141574 Process for Manufacturing Chewable Dosage Forms for Drug Delivery and Products Thereof
06/07/2012US20120141564 Compositions and methods of treating inflammation
06/07/2012US20120141558 Alginate-based nanofibers and related scaffolds
06/07/2012US20120141553 Biocompatible polymer fibres for neuroimplants
06/07/2012US20120141548 Novel formulation of meloxicam
06/07/2012US20120141538 Modulators of the cx3cri receptor and therapeutic uses thereof
06/07/2012US20120141532 Botulinum Toxin Formulation
06/07/2012US20120141514 Use of a chemically-stabilized chlorite solution for inhibiting an antigen-specific immune response
06/07/2012US20120141513 Deuterated fingolimod
06/07/2012US20120141511 Clostridial toxin derivatives able to modify peripheral sensory afferent functions
1 ... 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 ... 1833